search
Back to results

Pilot Study of Warm Acupuncture in Treatment of Cold-sensitive Fibromyalgia Syndrome

Primary Purpose

Fibromyalgia

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
warm acupunctrue
Sponsored by
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fibromyalgia focused on measuring Fibromyalgia, cold-sensitive, needle warming moxibustion, randomized controlled trial, warm acupunctrue

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Meet the 1990 American College of Rheumatology (ACR) Research Classification Criteria for fibromyalgia;
  2. Be over 18 years of age;
  3. The type and dose of drugs used for fibromyalgia should be stable for at least 2 weeks;
  4. The VAS score of item 10 (sensitivity to cold) in FIQR scale ≧4 points;
  5. Sign informed consent.

Exclusion Criteria:

  1. Patients suffering from systemic or local acute infectious diseases;
  2. Patients with severe visceral diseases or physical weakness who cannot tolerate acupuncture treatment;
  3. Pregnant women.

Sites / Locations

  • Guang'anmen HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Warm acupuncture - observation group

Observation - warm acupuncture group

Arm Description

Sequence A: Participants will receive warm acupuncture for 20 minutes twice a week for eight weeks. Sequence B: Patients will be observed without any intervention for eight weeks.

Sequence A: Patients will be observed without any intervention for eight weeks. Sequence B: Participants will receive warm acupuncture for 20 minutes twice a week for eight weeks.

Outcomes

Primary Outcome Measures

The change of the VAS score for item 10 (susceptibility to cold) of the modified fibromyalgia Impact Questionnaire from baseline.
range from 0 to 10 cm with higher score indicating more sensitive to cold.

Secondary Outcome Measures

The change of the revised Fibromyalgia Impact Questionnaire (FIQR) from baseline
A self-administered questionnaire with 10 subscales, measuring fibromyalgia symptoms and function domains. FIQR total score ranges from 0 to 100, with higher scores indicating more severe symptoms.
The change of the Visual Analogue Scale (VAS) for pain from baseline.
Pain VAS, range, 0 to 10 cm, where higher scores indicated the perceived pain to be more severe.
The change of the Multidimensional Fatigue Inventory-20 (MFI-20) from baseline.
The Multidimensional Fatigue Inventory-20 (MFI-20) measures fatigue severity. The MFI-20 total score ranges from 0 to 80, with higher scores indicate more severe fatigue.
The change of the Perceived Stress Scale (PSS) from baseline.
The Perceived Stress Scale (PSS) is for measuring the perception of stress and The Perceived Stress Scale (PSS) is for measuring the perception of stress and current levels of experienced stress. Scores range from 0 to 56, with higher total score indicating a greater degree of symptom severity
The change of the Hamilton Anxiety Scale(HAMA) from baseline.
he Hamilton Anxiety Scale is used to assess the severity of anxiety symptoms and consists of 14 items, with higher scores indicating greater anxiety
The change of the Beck II Depression Inventory (BDI) from baseline.
The Beck II Depression Inventory (BDI) assesses the severity of depressive symptoms. Scores range from 0 to 39, with higher scores indicate a greater degree of depression severity.
The change of the Short Form-36 Health Status Questionnaire (SF-36) from baseline.
The Short Form-36 Health Status Questionnaire (SF-36), which measured health-related quality of life (range, 0 to 100, with higher scores indicating better perceived health status
The change of the Minimum Mental State Examination(MMSE) from baseline.
The Minimum Mental State Examination(MMSE) scores range from 0 to 30, with higher scores indicating better cognitive function
The change of the Pittsburgh Sleep Quality Index (PSQI) from baseline.
Scores on the Pittsburgh Sleep Quality Index (PSQI) range from 0 to 21, with higher scores indicating worse sleep quality.
Global Impression of Change (PGIC) questionnaire evaluated at week 16.
A questionnaire determine any change in overall symptom status from the beginning of the study to its conclusion (score range, 1 [very much improved] to 7 [very much worse).

Full Information

First Posted
January 25, 2022
Last Updated
February 24, 2023
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT05228990
Brief Title
Pilot Study of Warm Acupuncture in Treatment of Cold-sensitive Fibromyalgia Syndrome
Official Title
Clinical Study on Efficacy and Safety of Warm Acupuncture in Treatment of Cold-sensitive Fibromyalgia Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 14, 2022 (Actual)
Primary Completion Date
November 30, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Non-pharmaceutical therapies, such as acupuncture, hydrotherapy, and meditative exercises (such as Qigong (including Tai Chi and Ba-Duan-Jin), have been shown to reduce pain and improve physical function. The management recommendations of fibromyalgia issued by the European Union, Canada, Germany and Israel have all affirmed the "first-line" role of Non-pharmaceutical therapy. Because of its good efficacy and safety, acupuncture therapy has been recommended in the management guidelines and has broad application prospects. Warm acupuncture is a therapy combining acupuncture and moxibustion, which is widely used in the treatment of various painful diseases in China, especially for cold-sensitive patients . This study aims to observe the safety and effectiveness of warm acupuncture in the treatment of cold-sensitive fibromyalgia patients, in order to provide a more alternative non-drug therapy for this particular type of patients with fibromyalgia .

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia
Keywords
Fibromyalgia, cold-sensitive, needle warming moxibustion, randomized controlled trial, warm acupunctrue

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
38 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Warm acupuncture - observation group
Arm Type
Experimental
Arm Description
Sequence A: Participants will receive warm acupuncture for 20 minutes twice a week for eight weeks. Sequence B: Patients will be observed without any intervention for eight weeks.
Arm Title
Observation - warm acupuncture group
Arm Type
Experimental
Arm Description
Sequence A: Patients will be observed without any intervention for eight weeks. Sequence B: Participants will receive warm acupuncture for 20 minutes twice a week for eight weeks.
Intervention Type
Device
Intervention Name(s)
warm acupunctrue
Other Intervention Name(s)
warm needling method, needle warming moxibustion, acupuncture with warmed needle
Intervention Description
The sterile acupuncture needle (0.3mm×40mm) is taken, and the acupuncture needle is vertically inserted into the corresponding depth of the acupoint. After the needle is transported to "get qi", moxibustion will be added at acupoints. The moxibustion distance is about 3cm from the skin, and the local temperature is warm and the patient felt comfortable with the skin. Replace it after burning out. During the acupuncture treatment, in order to avoid burns, it is necessary to strictly control the distance between moxibustion and skin. In the supine position, cardboard should be placed between moxibustion and skin to prevent burns, and ashes should be removed after moxibustion is completely burned. The needle is left for 20 minutes.
Primary Outcome Measure Information:
Title
The change of the VAS score for item 10 (susceptibility to cold) of the modified fibromyalgia Impact Questionnaire from baseline.
Description
range from 0 to 10 cm with higher score indicating more sensitive to cold.
Time Frame
Baseline, week4, week8, week12, week16
Secondary Outcome Measure Information:
Title
The change of the revised Fibromyalgia Impact Questionnaire (FIQR) from baseline
Description
A self-administered questionnaire with 10 subscales, measuring fibromyalgia symptoms and function domains. FIQR total score ranges from 0 to 100, with higher scores indicating more severe symptoms.
Time Frame
Baseline, week4, week8, week12, week16
Title
The change of the Visual Analogue Scale (VAS) for pain from baseline.
Description
Pain VAS, range, 0 to 10 cm, where higher scores indicated the perceived pain to be more severe.
Time Frame
Baseline, week4, week8, week12, week16
Title
The change of the Multidimensional Fatigue Inventory-20 (MFI-20) from baseline.
Description
The Multidimensional Fatigue Inventory-20 (MFI-20) measures fatigue severity. The MFI-20 total score ranges from 0 to 80, with higher scores indicate more severe fatigue.
Time Frame
Baseline, week4, week8, week12, week16
Title
The change of the Perceived Stress Scale (PSS) from baseline.
Description
The Perceived Stress Scale (PSS) is for measuring the perception of stress and The Perceived Stress Scale (PSS) is for measuring the perception of stress and current levels of experienced stress. Scores range from 0 to 56, with higher total score indicating a greater degree of symptom severity
Time Frame
Baseline, week4, week8, week12, week16
Title
The change of the Hamilton Anxiety Scale(HAMA) from baseline.
Description
he Hamilton Anxiety Scale is used to assess the severity of anxiety symptoms and consists of 14 items, with higher scores indicating greater anxiety
Time Frame
Baseline, week4, week8, week12, week16
Title
The change of the Beck II Depression Inventory (BDI) from baseline.
Description
The Beck II Depression Inventory (BDI) assesses the severity of depressive symptoms. Scores range from 0 to 39, with higher scores indicate a greater degree of depression severity.
Time Frame
Baseline, week4, week8, week12, week16
Title
The change of the Short Form-36 Health Status Questionnaire (SF-36) from baseline.
Description
The Short Form-36 Health Status Questionnaire (SF-36), which measured health-related quality of life (range, 0 to 100, with higher scores indicating better perceived health status
Time Frame
Baseline, week4, week8, week12, week16
Title
The change of the Minimum Mental State Examination(MMSE) from baseline.
Description
The Minimum Mental State Examination(MMSE) scores range from 0 to 30, with higher scores indicating better cognitive function
Time Frame
Baseline, week4, week8, week12, week16
Title
The change of the Pittsburgh Sleep Quality Index (PSQI) from baseline.
Description
Scores on the Pittsburgh Sleep Quality Index (PSQI) range from 0 to 21, with higher scores indicating worse sleep quality.
Time Frame
Baseline, week4, week8, week12, week16
Title
Global Impression of Change (PGIC) questionnaire evaluated at week 16.
Description
A questionnaire determine any change in overall symptom status from the beginning of the study to its conclusion (score range, 1 [very much improved] to 7 [very much worse).
Time Frame
week16

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Meet the 1990 American College of Rheumatology (ACR) Research Classification Criteria for fibromyalgia; Be over 18 years of age; The type and dose of drugs used for fibromyalgia should be stable for at least 2 weeks; The VAS score of item 10 (sensitivity to cold) in FIQR scale ≧4 points; Sign informed consent. Exclusion Criteria: Patients suffering from systemic or local acute infectious diseases; Patients with severe visceral diseases or physical weakness who cannot tolerate acupuncture treatment; Pregnant women.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yang Li, MM
Phone
+8601088001132
Ext
+8601088001132
Email
liyang99280@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
Juan Jiao, MD PhD
Phone
+8601088001132
Ext
+8601088001132
Email
jiao.juan@hotmail.com
Facility Information:
Facility Name
Guang'anmen Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100053
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Juan Jiao, MD. PhD.
Phone
+8688001060
Email
jiao.juan@hotmail.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Pilot Study of Warm Acupuncture in Treatment of Cold-sensitive Fibromyalgia Syndrome

We'll reach out to this number within 24 hrs